Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gelders Yg"'
Publikováno v:
Pharmacopsychiatry. 23:206-211
Sixty-one adult psychotic patients were treated for four weeks in an open dose-finding study with the new combined serotonin-dopamine antagonist risperidone (R 64 766). Risperidone had a rapid onset of action; a highly significant decrease in the tot
Publikováno v:
Psychiatry and Psychobiology. 5:319-324
RésuméDans le cadre d’une étude en ouvert portant sur la détermination de la posologie et après une période de sevrage thérapeutique d’une semaine, quarante patients adultes psychotiques chroniques sélectionnés selon les critères du DSM
Autor:
Gelders Yg, Marie-Lise J. A. Hoppenbrouwers, André Reyntjens, Paul A. J. Janssen, Dominique L. S. Ceulemans
Publikováno v:
Psychopharmacology. 85:329-332
The new antipsychotic drug setoperone is pharmacologically characterized by its potent serotonin and moderate dopamine receptor blocking properties. Forty chronic schizophrenic patients were included and 34 completed this pilot study. Following a dru
Autor:
Gelders Yg
Publikováno v:
British Journal of Psychiatry. 155:33-36
The pharmacotherapy of psychotic disorders which started in 1952, based on empirical results obtained with chlorpromazine by Delay & Deniker, has revolutionised the treatment of psychiatric diseases of non-organic origin. The discovery of haloperidol
Publikováno v:
Drug Development Research. 8:205-211
Ritanserin, characterized as a long-acting serotonin-S2 antagonist and as a pure and selective antagonist of LSD discrimination in rats, was found to be effective in the treatment of anxiety states. In these studies the observation that the patients
Publikováno v:
Pharmacopsychiatry. 18(5)
A double-blind study was performed in 83 patients with generalized anxiety disorder comparing daily doses of 5 and 10 mg ritanserin (a selective antagonist of serotonine S2 receptors) versus placebo and 4 mg lorazepam as reference drug. Patients trea
Publikováno v:
International pharmacopsychiatry. 17(4)
239 psychotic patients entered a 52-week open study comparing the efficacy and safety of intramuscular haloperidol decanoate, injected once every 4 weeks, with that of their previous maintenance therapy. Haloperidol decanoate, given at a medium month
Publikováno v:
Psychopharmacology. 99(4)
Risperidone (R 64766) was administered during 4 weeks in increasing doses to 17 psychotic patients, to evaluate the hematological and cardiovascular safety, the therapeutic effect, side effects, effects upon endocrinological parameters and the pharma
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.